The 31 references in paper M. Pashenkov V., B. Alkhazova I., V. L'vov L., B. Pinegin V., М. Пащенков В., Б. Алхазова И., В. Львов Л., Б. Пинегин В. (2014) “ПРИМЕНЕНИЕ ИНГИБИТОРНОГО АНАЛИЗА ДЛЯ ИЗУЧЕНИЯ МЕХАНИЗМОВ ДЕЙСТВИЯ МУРАМИЛПЕПТИДНОГО ИММУНОМОДУЛЯТОРА «ПОЛИМУРАМИЛ» // APPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR” / spz:neicon:mimmun:y:2013:i:1:p:21-28

1
Пащенков М.В., Попилюк С.Ф., Алхазова Б.И., Львов В.Л., Феденко Е.С., Хаитов Р.М., Пинегин Б.В. Иммунобиологические свойства мурамилпептидных фрагментов пептидогликана грамотрицательных бактерий // Иммунология. –
(check this in PDF content)
2
10. – Т. 31. – С. 119-125. 2. Пащенков М.В., Будихина А.С., Голубева Н.М., Алхазова Б.И., Елисютина О.Г., Львов В.Л., Феденко Е.С., Пинегин Б.В., Хаитов Р.М. Результаты I фазы клинических испытаний иммуномодулятора «Полимурамил» // Иммунология. – 2011. – Т. 32. – С. 239-243.
(check this in PDF content)
3
Пащенков М.В., Будихина А.С., Голубева Н.М., Алхазова Б.И., Львов В.Л., Ступин В.А., Привиденцев А.И., Трушин С.Н., Селиверстов Д.В., Огорельцев А.Ю., Пинегин Б.В., Хаитов Р.М. Клиническая и иммунологическая эффективность иммуномодулятора Полимурамил при гнойной хирургической инфекции // Физиология и патология иммунной системы. Иммунофармакогеномика. – 2011. – Т. 15. – С. 12-18.
(check this in PDF content)
4
Billmann-Born S., Till A., Arlt A., Lipinski S., Sina C., Latiano A., Annese V., Hasler R., Kerick M., Manke T., Seegert D., Hanidu A., Schafer H., van Heel D., Li J., Schreiber S., Rosenstiel P. Genome-wide expression profiling identifies an impairment of negative feedback signals in the Crohn’s disease-associated NOD2 variant L1007fsinsC // J. Immunol. – 2011. – Vol. 186. – P. 4027-4038.
(check this in PDF content)
5
Chamaillard M., Hashimoto M., Horie Y., Masumoto J., Qiu S., Saab L., Ogura Y., Kawasaki A., Fukase K., Kusumoto S., Valvano M.A., Foster S.J., Mak T.W., Nunez G., Inohara N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid // Nat. Immunol. – 2003. – Vol. 4. – P. 702-707.
(check this in PDF content)
6
Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection // J. Biol. Chem. – 2003. – Vol. 278. – P. 8869-8872.
(check this in PDF content)
7
Girardin S.E., Travassos L.H., Herve M., Blanot D., Boneca I. G., Philpott D.J., Sansonetti P.J., Mengin-Lecreulx D. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2 // J. Biol. Chem. – 2003. – Vol. 278. – P. 41702-41708.
(check this in PDF content)
8
Godl K., Wissing J., Kurtenbach A., Habenberger P., Blencke S., Gutbrod H., Salassidis K., Stein-Gerlach M., Missio A., Cotten M., Daub H. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors // Proc Natl Acad Sci USA. – 2003. – Vol. 100. – P. 15434-15439.
(check this in PDF content)
9
Huang T.T., Feinberg S.L., Suryanarayanan S., Miyamoto S. The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors // Mol. Cell Biol. – 2002. – Vol. 22. – P. 5813-5825.
(check this in PDF content)
10
Kagan J. C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta // Nat. Immunol. – 2008. – Vol. 9. – P. 361-368.
(check this in PDF content)
11
Kanneganti T.D., Lamkanfi M., Kim Y.G., Chen G., Park J.H., Franchi L., Vandenabeele P., Nunez G. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling // Immunity. – 2007. – Vol. 26. – P. 433443.
(check this in PDF content)
12
Kersse K., Bertrand M.J., Lamkanfi M., Vandenabeele P. NOD-like receptors and the innate immune system: coping with danger, damage and death // Cytokine Growth Factor Rev. – 2011. – Vol. 22. – P. 257-276.
(check this in PDF content)
13
Leber J.H., Crimmins G.T., Raghavan S., Meyer-Morse N.P., Cox J.S., Portnoy D.A. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen // PLoS Pathog. – 2008. – Vol. 4. – P. e6.
(check this in PDF content)
14
Lee J., Tattoli I., Wojtal K.A., Vavricka S.R., Philpott D.J., Girardin S.E. pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling // J. Biol. Chem. – 2009. – Vol. 284. – P. 23818-23829.
(check this in PDF content)
15
Macia E., Ehrlich M., Massol R., Boucrot E., Brunner C., Kirchhausen T. Dynasore, a cellpermeable inhibitor of dynamin // Dev. Cell. – 2006. – Vol. 10. – P. 839-850.
(check this in PDF content)
16
Marina-Garcia N., Franchi L., Kim Y.G., Hu Y., Smith D.E., Boons G.J., Nunez G. Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation // J. Immunol. – 2009. – Vol. 182. – P. 4321-4327.
(check this in PDF content)
17
Marina-Garcia N., Franchi L., Kim Y.G., Miller D., McDonald C., Boons G.J., Nunez G. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2 // J. Immunol. – 2008. – Vol. 180. – P. 4050-4057.
(check this in PDF content)
18
Masumoto J., Yang K., Varambally S., Hasegawa M., Tomlins S.A., Qiu S., Fujimoto Y., Kawasaki A., Foster S.J., Horie Y., Mak T.W., Nunez G., Chinnaiyan A.M., Fukase K., Inohara N. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo // J. Exp. Med. – 2006. – Vol. 203. – P. 203-213.
(check this in PDF content)
19
Meshcheryakova E., Makarov E., Philpott D., Andronova T., Ivanov V. Evidence for correlation between the intensities of adjuvant effects and NOD2 activation by monomeric, dimeric and lipophylic derivatives of N-acetylglucosaminylN-acetylmuramyl peptides // Vaccine. – 2007. – Vol. 25. – P. 4515-4520.
(check this in PDF content)
20
Nardin A., Lefebvre M.L., Labroquere K., Faure O., Abastado J.P. Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma // Curr Cancer Drug Targets. – 2006. – Vol. 6. – P. 123-133.
(check this in PDF content)
21
Park J.H., Kim Y.G., McDonald C., Kanneganti T.D., Hasegawa M., Body-Malapel M., Inohara N., Nunez G. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs // J. Immunol. – 2007. – Vol. 178. – P. 2380-2386.
(check this in PDF content)
22
Pashenkov M.V., Popilyuk S.F., Alkhazova B.I., L’vov V.L., Murugin V.V., Fedenko E.S., Khaitov R.M., Pinegin B.V. Muropeptides trigger distinct activation profiles in macrophages and dendritic cells // Int. Immunopharmacol. – 2010. – Vol. 10. – P. 875-882.
(check this in PDF content)
23
Tigno-Aranjuez J.T., Asara J.M., Abbott D.W. Inhibition of RIP2’s tyrosine kinase activity limits NOD2-driven cytokine responses // Genes Dev. – 2010. – Vol. 24. – P. 2666-2677.
(check this in PDF content)
24
Ting J.P., Duncan J.A., Lei Y. How the noninflammasome NLRs function in the innate immune system // Science. – 2010. – Vol. 327. – P. 286-290.
(check this in PDF content)
25
Trajkovic V., Samardzic T., Stosic-Grujicic S., Ramic Z., Mostarica Stojkovic M. Muramyl dipeptide potentiates cytokine-induced activation of inducible nitric oxide synthase in rat astrocytes // Brain Res. – 2000. – Vol. 883. – P. 157-163.
(check this in PDF content)
26
Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system // Ann. Rev. Immunol. – 2009. – Vol. 27. – P. 693-733.
(check this in PDF content)
27
Vavricka S.R., Musch M.W., Chang J.E., Nakagawa Y., Phanvijhitsiri K., Waypa T.S., Merlin D., Schneewind O., Chang E.B. hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells // Gastroenterology. – 2004. – Vol. 127. – P. 1401-1409.
(check this in PDF content)
28
Vinnitskii L.I., Buniatian K.A., Pinegin B.V., Mironova E.V., Shvets L.I., Volkov A.A., Inviiaeva E.V., Andronova T.M., Khaitov R.M. Domestic immunomodulator of a new generation, Licopid, in the comprehensive therapy and prevention of infectious complications in surgery // Vestn. Ross. Akad. Med. Nauk. – 1997. – P. 46-49.
(check this in PDF content)
29
Voss E., Wehkamp J., Wehkamp K., Stange E.F., Schroder J.M., Harder J. NOD2/ CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2 // J. Biol. Chem. – 2006. – Vol. 281. – P. 2005-2011.
(check this in PDF content)
30
West M.A., Bennet T., Seatter S.C., Clair L., Bellingham J. LPS pretreatment reprograms macrophage LPS-stimulated TNF and IL-1 release without protein tyrosine kinase activation // J. Leukoc. Biol. – 1997. – Vol. 61. – P. 88-95.
(check this in PDF content)
31
Windheim M., Lang C., Peggie M., Plater L.A., Cohen P. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide // Biochem. J. – 2007. – Vol. 404. – P. 179190.
(check this in PDF content)